method of obtaining \u0438\u043d\u0430\u043a\u0442\u0438\u0432\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0439 \u0446\u0435\u043b\u044c\u043d\u043e\u0432\u0438\u0440\u0438\u043e\u043d\u043d\u043e\u0439 \u0433\u0438\u0434\u0440\u043e\u043e\u043a\u0438\u0441\u044c\u0430\u043b\u044e\u043c\u0438\u043d\u0438\u0435\u0432\u043e\u0439 vaccine against influenza a \/ h1n1.the invention relates to the medical biotechnology and is a way to obtain \u0438\u043d\u0430\u043a\u0442\u0438\u0432\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0439 \u0446\u0435\u043b\u044c\u043d\u043e\u0432\u0438\u0440\u0438\u043e\u043d\u043d\u043e\u0439 \u0433\u0438\u0434\u0440\u043e\u043e\u043a\u0438\u0441\u044c\u0430\u043b\u044e\u043c\u0438\u043d\u0438\u0435\u0432\u043e\u0439 vaccine to in the influenza a \/ h1n1 in with n strainIBRG - 121xp obtained by reverse genetics at the national institute for biological standards and control (NIBSC,the united kingdom) and submitted to the world health organization \u043d\u0438\u0438\u043f\u0431\u0431 ncb kn mes rk for the development of \u043f\u0430\u043d\u0434\u0435\u043c\u0438\u0447\u0435\u0441\u043a\u043e\u0439 vaccine.provide a way of obtaining \u0438\u043d\u0430\u043a\u0442\u0438\u0432\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0439 \u0446\u0435\u043b\u044c\u043d\u043e\u0432\u0438\u0440\u0438\u043e\u043d\u043d\u043e\u0439 \u0433\u0438\u0434\u0440\u043e\u043e\u043a\u0438\u0441\u044c\u0430\u043b\u044e\u043c\u0438\u043d\u0438\u0435\u0432\u043e\u0439 vaccine against influenza a \/ h1n1 virus on the basis of the strain with NIBRG - 121xp,where the virus is cultivated in 10 - 11 daily chicken fetal, \u0438\u043d\u0430\u043a\u0442\u0438\u0432\u0438\u0440\u0443\u0435\u0442\u0441\u044f \u0444\u043e\u0440\u043c\u0430\u043b\u0438\u043d\u043e\u043c for optimal treatment.purified and concentrated by chromatography based methods and filtration and immunologic adjuvant aluminium hydroxide is added.the vaccine is a transparent liquid, \u043e\u0441\u0430\u04
